63,888 restricted shares awarded to Pediatrix (MD) strategy chief

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Pediatrix Medical Group EVP and Chief Investment & Strategy Officer Don Gregory Neeb reported routine equity compensation activity. He received a grant of 63,888 restricted shares of common stock under the company’s Second Amended and Restated 2008 Incentive Compensation Plan as part of an annual equity award.

According to the vesting schedule, 25% of these restricted shares will vest on June 1, 2027, 25% on June 1, 2028, and 50% on June 1, 2029, subject to the plan’s terms. In a related tax-withholding disposition, 8,003 restricted shares were withheld to cover taxes upon vesting of shares. After these entries, Neeb directly holds 145,234 Pediatrix common shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Neeb Don Gregory

Role EVP, Chief Invest & Strategy

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	63,888	$0.00	--
Tax Withholding	Common Stock	8,003	$21.54	$172K

Holdings After Transaction: Common Stock — 145,234 shares (Direct, null)

Footnotes (1)

Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan. Represents 8,003 restricted shares withheld for payment of taxes upon vesting of shares.

Key Figures

Restricted stock grant: 63,888 shares Tax-withheld shares: 8,003 shares at $21.54 Post-transaction holdings: 145,234 shares

3 metrics

Restricted stock grant 63,888 shares Annual equity award under 2008 Incentive Compensation Plan

Tax-withheld shares 8,003 shares at $21.54 Shares withheld to pay taxes upon vesting

Post-transaction holdings 145,234 shares Common stock held directly after reported transactions

Key Terms

Restricted shares, Second Amended and Restated 2008 Incentive Compensation Plan, taxes upon vesting, grant, award, or other acquisition

4 terms

Restricted shares financial

"Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Second Amended and Restated 2008 Incentive Compensation Plan financial

"granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan"

taxes upon vesting financial

"Represents 8,003 restricted shares withheld for payment of taxes upon vesting of shares"

grant, award, or other acquisition financial

"transaction code description indicates Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/03/2026 - 05:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Neeb Don Gregory

(Last)

(First)

(Middle)

1301 CONCORD TERRACE

(Street)

SUNRISE

FLORIDA

33323

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pediatrix Medical Group, Inc. [ MD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Chief Invest & Strategy

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/01/2026		A⁽¹⁾		63,888	A	$0	145,234	D
Common Stock	06/01/2026		F⁽²⁾		8,003	D	$21.54	137,231	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan.

2. Represents 8,003 restricted shares withheld for payment of taxes upon vesting of shares.

	/s/ Mary Ann E. Moore, Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Pediatrix (MD) executive Don Gregory Neeb report?

Don Gregory Neeb reported a grant of 63,888 restricted Pediatrix shares and a related withholding of 8,003 shares for taxes. These entries are compensation-related, not open-market trades, and reflect routine equity award and tax-settlement activity.

How many Pediatrix (MD) shares does Don Gregory Neeb hold after this Form 4?

After the reported transactions, Don Gregory Neeb directly holds 145,234 shares of Pediatrix common stock. This figure reflects the new restricted stock grant and the 8,003 restricted shares withheld to satisfy tax obligations upon vesting.

What are the vesting terms of Don Gregory Neeb’s 63,888 restricted Pediatrix shares?

The 63,888 restricted shares vest in stages: 25% on June 1, 2027, another 25% on June 1, 2028, and the remaining 50% on June 1, 2029. Vesting is subject to the terms of Pediatrix’s Second Amended and Restated 2008 Incentive Compensation Plan.

Was there an open-market sale or purchase by Pediatrix (MD) executive Don Gregory Neeb?

The Form 4 shows no open-market purchase or sale. Activity consists of a restricted stock grant and 8,003 shares withheld for taxes upon vesting, which are compensation and tax-settlement mechanisms rather than discretionary market trades.

Why were 8,003 Pediatrix shares withheld for Don Gregory Neeb on this Form 4?

The 8,003 Pediatrix shares represent restricted stock withheld to pay taxes due upon vesting of shares. This tax-withholding disposition is a common administrative step for equity awards and does not represent an open-market sale by the executive.